Valvular & structural heart diseaseCohort study

Potentially futile outcome after uncomplicated transcatheter aortic valve implantation (TAVI): Insights from the transfusion requirements in transcatheter aortic valve implantation (TRITAVI) registry

Am Heart JPublished

  • international, investigator-initiated registry
  • 18 European sites

Authors' conclusion

Risk of death between 30 days and 1 year after noncomplicated TAVI is not negligible even for patients without major peri-procedural complications. It appears mainly driven by non-CV reasons and predicted by baseline renal function, baseline LVEF, and atrial fibrillation.

Study context

Population
Patients with symptomatic severe aortic stenosis undergoing TAVIpatients included
Participants
11,246 patients
Outcome
All-cause death between 30 days and 1 year without major peri-procedural complications (major vascular complications, stage 2 to 3 acute kidney injury (AKI) and transfusions)
Follow-up
Between 30 days and 1 year

Main finding

As reported in the abstract

Died between 1 and 12 months without major peri-procedural complications

454 (4%)

Of these, died for cardiovascular reasons

78 (0.7%)

Of these, died for noncardiovascular reasons

376 (3.3%)

Observational data: associations, not effects.

Further findings

Predictors of the primary end point

ComparisonHR (95% CI)P value
COPD1.35 (1.05–1.73)P = 0.002
Atrial Fibrillation1.46 (1.16–1.84)P = 0.001
severe Chronic Kidney Disease (CKD)1.70 (1.10–2.62)P = 0.018
moderate reduction of LVEF1.42 (1.07–1.90)P = 0.017
severe reduction of LVEF1.62 (1.17–2.23)P = 0.003

Predictors of non-CV death

ComparisonHR (95% CI)P value
baseline creatinine · increased risk1.2 (1.1–1.4)P = 0.002
AF · increased risk1.4 (1.1–1.8)P = 0.008
higher baseline LVEF · lower risk0.9 (0.8–0.99)P < 0.001

Competing risk analysis: non-CV vs CV death

Risk of non-CV death appeared more relevant and steadily increased across the year, while risk of CV death was lower

Original publication

Potentially futile outcome after uncomplicated TAVI: Insights from the TRITAVI registry. Am Heart J. Published 27 May 2026. doi:10.1016/j.ahj.2026.107488

Summarised from the published abstract; every number is checked against it